Keros Therapeutics, Inc. (KROS) Dividend Yield, History & Forecast
Keros Therapeutics, Inc. (KROS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Market. market capitalization is approximately $447M.
Frequently Asked Questions about Keros Therapeutics, Inc. (KROS)
Is Keros Therapeutics, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Keros Therapeutics, Inc. in?▾
Keros Therapeutics, Inc. (KROS) operates in the Healthcare sector, specifically the Biotechnology industry.
